|

Rivaroxaban (Xarelto) Clinical Trials

1 actively recruiting trial

Also known as: Anticoagulation

Pipeline

Phase 4: 1

Top Sponsors

  • Children's Hospital of Fudan University1

Indications

  • Rivaroxaban1
  • Coronary Artery Aneurysm1
  • Pilot Study1
  • Heart Disease1
  • Kawasaki Disease1

Other1 trial

Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.